Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug:97:236-239.
doi: 10.1016/j.ijid.2020.06.056. Epub 2020 Jun 18.

Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: Mini-review of the literature

Alessandra D'Abramo  1 , Luciana Lepore  1 , Claudia Palazzolo  2 , Filippo Barreca  3 , Giuseppina Liuzzi  1 , Eleonora Lalle  1 , Emanuele Nicastri  1
Affiliations
Case Reports

Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: Mini-review of the literature

Alessandra D'Abramo et al. Int J Infect Dis. 2020 Aug.

Abstract

A case of acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection and a mini-review of the literature is reported. Even in COVID-19 epidemics, the early identification of concurrent respiratory pathogens is important to improve etiological diagnosis, preventive measures and patients' clinical management and outcome.

Keywords: Acute respiratory distress syndrome; COVID-19 epidemic; Influenza A; SARS-CoV-2.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chest computer tomography scan at patient’s worsening and recovery. (a) Bilateral ground-glass opacities with fibrotic consolidation in both lower pulmonary lobes (b) reduction of the ground glass areas with residual interstitial damage.
See this image and copyright information in PMC

References

    1. Azekawa S., Namkoong H., Mitamura K., Kawaoka Y., Saito F. Co-infection with SARS-CoV-2 and influenza A virus. IDCases. 2020;20(April) doi: 10.1016/j.idcr.2020.e00775. - DOI - PMC - PubMed
    1. Blasco M.L., Buesa J., Colomina J., Forner M.J., Galindo M.J., Navarro J. Co-detection of respiratory pathogens in patients hospitalized with coronavirus viral disease-2019 pneumonia. J Med Virol. 2020;(April) doi: 10.1002/jmv.25922. - DOI - PubMed
    1. Cao B., Wang Y., Wen D., Liu W., Wang J., Fan G. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382(May (19)):1787–1799. doi: 10.1056/NEJMoa2001282. - DOI - PMC - PubMed
    1. Chan J.F., Yao Y., Yeung M.L., Deng W., Bao L., Jia L. Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J Infect Dis. 2015;212(12):1904–1913. - PMC - PubMed
    1. Chan J.F., Kok K.H., Zhu Z., Chu H., To K.K., Yuan S. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(January (1)):221–236. doi: 10.1080/22221751.2020.1719902. - DOI - PMC - PubMed

Publication types